Prader-Willi syndrome groups raise safety concerns over first approved hyperphagia drug Vykat XR

Advocacy groups for Prader-Willi syndrome have issued a warning about potential safety risks associated with Vykat XR, the first medication approved for managing extreme hunger in affected individuals, amid reports of serious adverse events and fatalities. Prader-Willi syndrome advocacy groups…















